epirubicin has been researched along with Mesothelioma in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (64.29) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kahlos, K; Kinnula, V; Koistinen, P; Mäntymaa, P; Pääkkö, P; Säily, M; Soini, Y; Sormunen, R | 1 |
| Berchier, MC; Berghmans, T; Collon, T; Lafitte, JJ; Lecomte, J; Mommen, P; Paesmans, M; Sculier, JP; Stach, B; Wackenier, P | 1 |
| Chella, A; Dini, P; Fontanini, G; Lucchi, M; Melfi, F; Mussi, A; Tibaldi, C | 1 |
| Adjei, AA; Aubry, MC; Delaune, R; Foster, NR; Kardinal, CG; Maurer, MJ; Nikcevich, DA; Northfelt, DW; Okuno, SH; Rowland, KM; Sloan, JA; Soori, GS | 1 |
| Adamo, C; Angeletti, CA; Chella, A; Dini, P; Mussi, A; Ribechini, A | 1 |
| Anttila, S; Asikainen, T; Kahlos, K; Kinnula, K; Kinnula, VL; Linnainmaa, K; Mattson, K; Raivio, KO | 1 |
| Kinnula, K; Kinnula, VL; Linnainmaa, K; Raivio, KO | 1 |
| Agrawal, AK; Gupta, NP; Hemal, AK; Nair, M; Sood, S | 1 |
| Armand, JP; Evans, TR; Seymour, L | 1 |
| Kaarteenaho-Wiik, R; Kahlos, K; Kinnula, VL; Linnainmaa, K; Pääkkö, P; Soini, Y; Sormunen, R | 1 |
| Evrard, D; Giaccone, G; Kirkpatrick, A; Mattson, K; Planteydt, HT; Tammilehto, L; van Breukelen, FJ; van Zandwijk, N | 1 |
| Bianchi, C; Foladore, S; Grandi, G; Magri, MD; Monfardini, S; Nicotra, M; Serra, C; Tommasi, M; Veronesi, A | 1 |
| Hassel, J; Lindemann, F; Slawik, HR; Wagner, T; Wienbeck, M | 1 |
| Crismancich, F; De Giovanni, D; Foladore, S; Magri, MD; Morassut, S; Nicotra, M; Serra, C; Tommasi, M; Tuveri, G; Veronesi, A | 1 |
1 review(s) available for epirubicin and Mesothelioma
| Article | Year |
|---|---|
Malignant mesothelioma of the tunica vaginalis testis: a report of two cases and review of literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diagnosis, Differential; Drug Administration Schedule; Epirubicin; Humans; Ifosfamide; Male; Mesothelioma; Testicular Neoplasms; Testis | 1999 |
7 trial(s) available for epirubicin and Mesothelioma
| Article | Year |
|---|---|
A phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesothelioma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Female; Humans; Infusions, Intravenous; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Prognosis; Survival Analysis; Treatment Outcome | 2005 |
Four-modality therapy in malignant pleural mesothelioma: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Deoxycytidine; Epirubicin; Feasibility Studies; Female; Gemcitabine; Humans; Interleukin-2; Male; Mesothelioma; Middle Aged; Pleura; Pleural Neoplasms; Radiotherapy, Adjuvant | 2007 |
A phase 2 study of gemcitabine and epirubicin for the treatment of pleural mesothelioma: a North Central Cancer Treatment Study, N0021.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease Progression; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Injections, Intravenous; Leukopenia; Male; Mesothelioma; Middle Aged; Neutropenia; Pleural Neoplasms; Quality of Life; Remission Induction; Ribonucleotide Reductases; Survival Rate; Thrombocytopenia; Treatment Outcome | 2008 |
Raltitrexed (Tomudex) in combination with platinum-based agents and/or anthracyclines: preliminary results of phase I clinical trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Digestive System Neoplasms; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Humans; Mesothelioma; Organoplatinum Compounds; Oxaliplatin; Quinazolines; Thiophenes; Treatment Outcome | 1999 |
Epirubicin in malignant mesothelioma: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
Topics: Adult; Aged; Drug Evaluation; Epirubicin; Female; Humans; Male; Mesothelioma; Middle Aged; Survival Analysis; Thoracic Neoplasms; Treatment Outcome | 1992 |
Treatment of malignant mesothelioma with epirubicin and ifosfamide: a phase II cooperative study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Humans; Ifosfamide; Male; Mesothelioma; Middle Aged | 1992 |
Epirubicin in the treatment of malignant mesothelioma: a phase II cooperative study. The North-Eastern Italian Oncology Group (GOCCNE)--Mesothelioma Committee.
Topics: Aged; Drug Evaluation; Epirubicin; Female; Humans; Lung Neoplasms; Male; Mesothelioma; Middle Aged | 1991 |
6 other study(ies) available for epirubicin and Mesothelioma
| Article | Year |
|---|---|
Activation and relocalization of caspase 3 during the apoptotic cascade of human mesothelioma cells.
Topics: Antibiotics, Antineoplastic; Apoptosis; Caspase 3; Caspase 8; Caspases; Enzyme Activation; Epirubicin; Fas Ligand Protein; fas Receptor; Humans; Membrane Glycoproteins; Mesothelioma; Tumor Cells, Cultured | 2005 |
[Treatment of malignant pleural effusion by percutaneous catheter drainage and chemical pleurodesis].
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Catheterization; Drainage; Epirubicin; Female; Humans; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Pleural Effusion, Malignant; Pleural Neoplasms; Pleurodesis; Propionibacterium acnes | 1994 |
Manganese superoxide dismutase in healthy human pleural mesothelium and in malignant pleural mesothelioma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antioxidants; Biopsy; Cell Line, Transformed; Epirubicin; Epithelial Cells; Free Radical Scavengers; Hemostatics; Humans; Hydrogen Peroxide; Male; Mesothelioma; Middle Aged; Pleura; Pleural Neoplasms; Superoxide Dismutase; Tumor Cells, Cultured; Vitamin K | 1998 |
Endogenous antioxidant enzymes and glutathione S-transferase in protection of mesothelioma cells against hydrogen peroxide and epirubicin toxicity.
Topics: Antibiotics, Antineoplastic; Antioxidants; Epirubicin; Glutathione Transferase; Humans; Hydrogen Peroxide; Mesothelioma; Oxidants; Tumor Cells, Cultured | 1998 |
Expression and prognostic significance of catalase in malignant mesothelioma.
Topics: Amitrole; Biomarkers, Tumor; Blotting, Western; Catalase; Epirubicin; Humans; Immunohistochemistry; Mesothelioma; Microscopy, Immunoelectron; Pleural Neoplasms; Prognosis; Superoxide Dismutase; Survival Rate; Tumor Cells, Cultured | 2001 |
[Sudden increase in abdominal circumference in a young man].
Topics: Adult; Ascites; Combined Modality Therapy; Diagnosis, Differential; Epirubicin; Humans; Male; Mesothelioma; Peritoneal Neoplasms; Peritoneum | 1991 |